| Balance sheet (USD) | Q2 2025 ended Jun 30, 2025 | Q2 2025 ended Mar 31, 2025 | Q2 2025 ended Jun 30, 2024 | Q2 2025 ended Mar 31, 2024 | Q2 2023 ended Jun 30, 2023 | Q2 2023 ended Mar 31, 2023 | Q2 2022 ended Jun 30, 2022 | Q2 2022 ended Mar 31, 2022 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.30M | 7.17M | 8.81M | |||||
| Total assets | 8.51M | 9.00M | 11.38M |
From Addex Therapeutics Ltd.'s 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.